期刊
JOURNAL OF PROTEOME RESEARCH
卷 6, 期 12, 页码 4549-4555出版社
AMER CHEMICAL SOC
DOI: 10.1021/pr070529w
关键词
biomarker; mass spectrometry; blood; urine; validation; diagnosis; prognosis
资金
- NIDDK NIH HHS [DK61525, DK47322, DK78244, DK71802, DK64400] Funding Source: Medline
- NIGMS NIH HHS [5T32GM08349, 1R01GM080148] Funding Source: Medline
Sparked by the article from Lescuyer and colleagues in a recent issue, we aim here to further encourage interest in and discussion of clinically relevant biomarker research. We express our view on proteomics for biomarker discovery by addressing multiple relevant issues, including the inherent differences between biological fluids (and how these differences affect current analytical approaches) and experimental design to maximize the efficiency of moving from the bench to the bedside. Herein, we also include suggestions for definition of the term biomarker, based on the use of a set of universal characterization/validation requirements, and illustrate several recent examples of successful transitions of benchtop proteomic studies work to clinical practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据